human nk cell enrichment kit (negative selection, easystep) Search Results


99
Miltenyi Biotec human cd4 t cell enrichment kit easysep
Human Cd4 T Cell Enrichment Kit Easysep, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cd4 t cell enrichment kit easysep/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
human cd4 t cell enrichment kit easysep - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easysep human cord blood cd34 positive selection kit
Easysep Human Cord Blood Cd34 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easysep human cord blood cd34 positive selection kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easysep human cord blood cd34 positive selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc magnetic beads easysep human cd4 positive selection kit ii
Magnetic Beads Easysep Human Cd4 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/magnetic beads easysep human cd4 positive selection kit ii/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
magnetic beads easysep human cd4 positive selection kit ii - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc human whole blood cd66b positive selection kit
Human Whole Blood Cd66b Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human whole blood cd66b positive selection kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
human whole blood cd66b positive selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
StemCells Inc easysep human cd138 positive selection kit
Easysep Human Cd138 Positive Selection Kit, supplied by StemCells Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easysep human cd138 positive selection kit/product/StemCells Inc
Average 90 stars, based on 1 article reviews
easysep human cd138 positive selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easysep cd33 selection kit
a , Percentages of human myeloid cells (hCD33 + ) among human hematopoietic cells (hCD45 + ) in the blood of the indicated recipient mice, engrafted as newborns by intra-hepatic injection of fetal liver CD34 + cells after X-ray preconditioning. Each symbol represents an individual mouse and the red bars indicate mean values (n=20-113; statistical analysis is shown in ). b , Composition of human white blood cells in the same mice as in a (n=20-113 mice/group; n=8 human donors; error bars indicate SEM). c , Immunohistological staining of human myeloid cells (hCD68 + ) in non-lymphoid tissues of the indicated recipient mice. The black bar represents 20 μm, and the images shown are representative of at least three mice analyzed per group. d-e , Representative flow cytometry analysis ( d ) and frequencies ( e ) of human monocyte subsets, identified by expression of CD14 and CD16 among hCD45 + <t>CD33</t> + cells in the blood of recipient mice (n=8-12 mice/group; error bars indicate SEM). Dot plots in d are gated on CD33 hi SSC lo cells to show the subset distribution among monocytic cells. f , Human monocytes in the blood of MISTRG recipients and human monocytes from a human donor were stained with the indicated antibodies. Staining with isotype control antibodies is shown in red and specific antibodies in blue.
Easysep Cd33 Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easysep cd33 selection kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easysep cd33 selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc anti-epcam (easysep human epcam positive selection cocktail ii)
a , Percentages of human myeloid cells (hCD33 + ) among human hematopoietic cells (hCD45 + ) in the blood of the indicated recipient mice, engrafted as newborns by intra-hepatic injection of fetal liver CD34 + cells after X-ray preconditioning. Each symbol represents an individual mouse and the red bars indicate mean values (n=20-113; statistical analysis is shown in ). b , Composition of human white blood cells in the same mice as in a (n=20-113 mice/group; n=8 human donors; error bars indicate SEM). c , Immunohistological staining of human myeloid cells (hCD68 + ) in non-lymphoid tissues of the indicated recipient mice. The black bar represents 20 μm, and the images shown are representative of at least three mice analyzed per group. d-e , Representative flow cytometry analysis ( d ) and frequencies ( e ) of human monocyte subsets, identified by expression of CD14 and CD16 among hCD45 + <t>CD33</t> + cells in the blood of recipient mice (n=8-12 mice/group; error bars indicate SEM). Dot plots in d are gated on CD33 hi SSC lo cells to show the subset distribution among monocytic cells. f , Human monocytes in the blood of MISTRG recipients and human monocytes from a human donor were stained with the indicated antibodies. Staining with isotype control antibodies is shown in red and specific antibodies in blue.
Anti Epcam (Easysep Human Epcam Positive Selection Cocktail Ii), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-epcam (easysep human epcam positive selection cocktail ii)/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
anti-epcam (easysep human epcam positive selection cocktail ii) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easysep human plasmacytoid dc enrichment kit
a , Percentages of human myeloid cells (hCD33 + ) among human hematopoietic cells (hCD45 + ) in the blood of the indicated recipient mice, engrafted as newborns by intra-hepatic injection of fetal liver CD34 + cells after X-ray preconditioning. Each symbol represents an individual mouse and the red bars indicate mean values (n=20-113; statistical analysis is shown in ). b , Composition of human white blood cells in the same mice as in a (n=20-113 mice/group; n=8 human donors; error bars indicate SEM). c , Immunohistological staining of human myeloid cells (hCD68 + ) in non-lymphoid tissues of the indicated recipient mice. The black bar represents 20 μm, and the images shown are representative of at least three mice analyzed per group. d-e , Representative flow cytometry analysis ( d ) and frequencies ( e ) of human monocyte subsets, identified by expression of CD14 and CD16 among hCD45 + <t>CD33</t> + cells in the blood of recipient mice (n=8-12 mice/group; error bars indicate SEM). Dot plots in d are gated on CD33 hi SSC lo cells to show the subset distribution among monocytic cells. f , Human monocytes in the blood of MISTRG recipients and human monocytes from a human donor were stained with the indicated antibodies. Staining with isotype control antibodies is shown in red and specific antibodies in blue.
Easysep Human Plasmacytoid Dc Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easysep human plasmacytoid dc enrichment kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easysep human plasmacytoid dc enrichment kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc negative magnetic selection kit easysep human cd4 + t cell isolation kit
a , Percentages of human myeloid cells (hCD33 + ) among human hematopoietic cells (hCD45 + ) in the blood of the indicated recipient mice, engrafted as newborns by intra-hepatic injection of fetal liver CD34 + cells after X-ray preconditioning. Each symbol represents an individual mouse and the red bars indicate mean values (n=20-113; statistical analysis is shown in ). b , Composition of human white blood cells in the same mice as in a (n=20-113 mice/group; n=8 human donors; error bars indicate SEM). c , Immunohistological staining of human myeloid cells (hCD68 + ) in non-lymphoid tissues of the indicated recipient mice. The black bar represents 20 μm, and the images shown are representative of at least three mice analyzed per group. d-e , Representative flow cytometry analysis ( d ) and frequencies ( e ) of human monocyte subsets, identified by expression of CD14 and CD16 among hCD45 + <t>CD33</t> + cells in the blood of recipient mice (n=8-12 mice/group; error bars indicate SEM). Dot plots in d are gated on CD33 hi SSC lo cells to show the subset distribution among monocytic cells. f , Human monocytes in the blood of MISTRG recipients and human monocytes from a human donor were stained with the indicated antibodies. Staining with isotype control antibodies is shown in red and specific antibodies in blue.
Negative Magnetic Selection Kit Easysep Human Cd4 + T Cell Isolation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/negative magnetic selection kit easysep human cd4 + t cell isolation kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
negative magnetic selection kit easysep human cd4 + t cell isolation kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easysep tm human cd138 positive selection kit
Prevalence and prognostic significance of S100 copy number change. (A) Location of the 17 S100 genes on chromosome 1q21.3. (B) Hierarchical clustering of S100 genes in <t>CD138+</t> plasma cells from 168 MM patient samples, using Euclidean distance matrix and complete clustering method, based on CNV score. (C) The increased copy number of S100 genes correlated with poor overall survival. (D) Kaplan-Meier curves for MM patients with or without S100 gain. Because patients with S100 gain were also more likely to have 1q21 gain, four groups were used for OS analysis and included: neither 1q21 gain nor S100 gain (Neither), 1q21 gain present but no S100 gain (only 1q21 gain), S100 gain present but no 1q21 gain (only S100 gain), and 1q21 gain and S100 gain present (Both). CNV score > 0.5 indicated a gain event, while <–0.6 is a deletion event. CNV, copy number variation; FIMM, Institute for Molecular Medicine Finland; OS, overall survival; HR, hazard ratio; CI, confidence interval.
Easysep Tm Human Cd138 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easysep tm human cd138 positive selection kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easysep tm human cd138 positive selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cd14 + magnetic beads easysep human cd14 positive selection kit ii
The intestinal microenvironment of Crohn’s disease patients promotes an inflammatory transcriptome in blood monocytes. [A–C] Differentially expressed transcriptomic pathways in blood <t>CD14</t> + monocytes from healthy donors treated for 5 h with [A] TREM-1 agonist antibody [5 µg/mL], [B] LP-CM from three controls or [C] LP-CM from three Crohn’s disease patients. Quantification of gene expression was done with the NanoString nCounter Human Myeloid Innate Immunity V2 Panel. Pathway signature scores condense each sample’s gene expression profile into a small set of pathway scores. An experiment can then be explored through the lens of pathway signature scores instead of in the much higher-dimension lens of gene expression values. Pathway signature scores are fit using the first principal component of each gene set’s data. They are orientated such that an increasing score corresponds to mostly increasing expression [specifically, each pathway score has positive weights for at least half its genes]. Covariates plots compare pathway signature scores to covariates. Red triangles and green triangles help to show the relative increase and decrease in pathways, respectively, compared to the control condition. [D] The 38 molecules that increased by a minimum two-fold in LP-CM from the three Crohn’s disease patients compared to LP-CM from the three controls. The fold change is based on the mean of the three values per group. [E] LP-CM inflammation score for each sample. This score is the mean of the linear NPX values [see Section 2.6] of the 38 proteins shown in D as a way to get a relative quantification of the inflammation status of the individuals analysed. [F] Correlations between the LP-CM inflammation scores and the top ten increased genes in human blood CD14 + monocytes treated with the Crohn’s disease LP-CM compared to cells treated with the control LP-CM [see ]. [G] Correlations between the LP-CM inflammation scores and the frequency of cells in the same individual determined by flow cytometry [gated as in ]. [F, G] Correlations were assessed by Spearman’s test. Abbreviations: Ctr, controls; LP-CM, lamina propria conditioned media; Mfs, macrophages.
Cd14 + Magnetic Beads Easysep Human Cd14 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd14 + magnetic beads easysep human cd14 positive selection kit ii/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
cd14 + magnetic beads easysep human cd14 positive selection kit ii - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easysep hla chimerism whole blood myeloid positive selection kit
The intestinal microenvironment of Crohn’s disease patients promotes an inflammatory transcriptome in blood monocytes. [A–C] Differentially expressed transcriptomic pathways in blood <t>CD14</t> + monocytes from healthy donors treated for 5 h with [A] TREM-1 agonist antibody [5 µg/mL], [B] LP-CM from three controls or [C] LP-CM from three Crohn’s disease patients. Quantification of gene expression was done with the NanoString nCounter Human Myeloid Innate Immunity V2 Panel. Pathway signature scores condense each sample’s gene expression profile into a small set of pathway scores. An experiment can then be explored through the lens of pathway signature scores instead of in the much higher-dimension lens of gene expression values. Pathway signature scores are fit using the first principal component of each gene set’s data. They are orientated such that an increasing score corresponds to mostly increasing expression [specifically, each pathway score has positive weights for at least half its genes]. Covariates plots compare pathway signature scores to covariates. Red triangles and green triangles help to show the relative increase and decrease in pathways, respectively, compared to the control condition. [D] The 38 molecules that increased by a minimum two-fold in LP-CM from the three Crohn’s disease patients compared to LP-CM from the three controls. The fold change is based on the mean of the three values per group. [E] LP-CM inflammation score for each sample. This score is the mean of the linear NPX values [see Section 2.6] of the 38 proteins shown in D as a way to get a relative quantification of the inflammation status of the individuals analysed. [F] Correlations between the LP-CM inflammation scores and the top ten increased genes in human blood CD14 + monocytes treated with the Crohn’s disease LP-CM compared to cells treated with the control LP-CM [see ]. [G] Correlations between the LP-CM inflammation scores and the frequency of cells in the same individual determined by flow cytometry [gated as in ]. [F, G] Correlations were assessed by Spearman’s test. Abbreviations: Ctr, controls; LP-CM, lamina propria conditioned media; Mfs, macrophages.
Easysep Hla Chimerism Whole Blood Myeloid Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easysep hla chimerism whole blood myeloid positive selection kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easysep hla chimerism whole blood myeloid positive selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a , Percentages of human myeloid cells (hCD33 + ) among human hematopoietic cells (hCD45 + ) in the blood of the indicated recipient mice, engrafted as newborns by intra-hepatic injection of fetal liver CD34 + cells after X-ray preconditioning. Each symbol represents an individual mouse and the red bars indicate mean values (n=20-113; statistical analysis is shown in ). b , Composition of human white blood cells in the same mice as in a (n=20-113 mice/group; n=8 human donors; error bars indicate SEM). c , Immunohistological staining of human myeloid cells (hCD68 + ) in non-lymphoid tissues of the indicated recipient mice. The black bar represents 20 μm, and the images shown are representative of at least three mice analyzed per group. d-e , Representative flow cytometry analysis ( d ) and frequencies ( e ) of human monocyte subsets, identified by expression of CD14 and CD16 among hCD45 + CD33 + cells in the blood of recipient mice (n=8-12 mice/group; error bars indicate SEM). Dot plots in d are gated on CD33 hi SSC lo cells to show the subset distribution among monocytic cells. f , Human monocytes in the blood of MISTRG recipients and human monocytes from a human donor were stained with the indicated antibodies. Staining with isotype control antibodies is shown in red and specific antibodies in blue.

Journal: Nature biotechnology

Article Title: Development and function of human innate immune cells in a humanized mouse model

doi: 10.1038/nbt.2858

Figure Lengend Snippet: a , Percentages of human myeloid cells (hCD33 + ) among human hematopoietic cells (hCD45 + ) in the blood of the indicated recipient mice, engrafted as newborns by intra-hepatic injection of fetal liver CD34 + cells after X-ray preconditioning. Each symbol represents an individual mouse and the red bars indicate mean values (n=20-113; statistical analysis is shown in ). b , Composition of human white blood cells in the same mice as in a (n=20-113 mice/group; n=8 human donors; error bars indicate SEM). c , Immunohistological staining of human myeloid cells (hCD68 + ) in non-lymphoid tissues of the indicated recipient mice. The black bar represents 20 μm, and the images shown are representative of at least three mice analyzed per group. d-e , Representative flow cytometry analysis ( d ) and frequencies ( e ) of human monocyte subsets, identified by expression of CD14 and CD16 among hCD45 + CD33 + cells in the blood of recipient mice (n=8-12 mice/group; error bars indicate SEM). Dot plots in d are gated on CD33 hi SSC lo cells to show the subset distribution among monocytic cells. f , Human monocytes in the blood of MISTRG recipients and human monocytes from a human donor were stained with the indicated antibodies. Staining with isotype control antibodies is shown in red and specific antibodies in blue.

Article Snippet: Human CD33 + cells were enriched by magnetic isolation (EasySep CD33 selection kit, StemCell Technologies).

Techniques: Injection, Staining, Flow Cytometry, Expressing, Control

Prevalence and prognostic significance of S100 copy number change. (A) Location of the 17 S100 genes on chromosome 1q21.3. (B) Hierarchical clustering of S100 genes in CD138+ plasma cells from 168 MM patient samples, using Euclidean distance matrix and complete clustering method, based on CNV score. (C) The increased copy number of S100 genes correlated with poor overall survival. (D) Kaplan-Meier curves for MM patients with or without S100 gain. Because patients with S100 gain were also more likely to have 1q21 gain, four groups were used for OS analysis and included: neither 1q21 gain nor S100 gain (Neither), 1q21 gain present but no S100 gain (only 1q21 gain), S100 gain present but no 1q21 gain (only S100 gain), and 1q21 gain and S100 gain present (Both). CNV score > 0.5 indicated a gain event, while <–0.6 is a deletion event. CNV, copy number variation; FIMM, Institute for Molecular Medicine Finland; OS, overall survival; HR, hazard ratio; CI, confidence interval.

Journal: Frontiers in Cell and Developmental Biology

Article Title: S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma

doi: 10.3389/fcell.2021.723016

Figure Lengend Snippet: Prevalence and prognostic significance of S100 copy number change. (A) Location of the 17 S100 genes on chromosome 1q21.3. (B) Hierarchical clustering of S100 genes in CD138+ plasma cells from 168 MM patient samples, using Euclidean distance matrix and complete clustering method, based on CNV score. (C) The increased copy number of S100 genes correlated with poor overall survival. (D) Kaplan-Meier curves for MM patients with or without S100 gain. Because patients with S100 gain were also more likely to have 1q21 gain, four groups were used for OS analysis and included: neither 1q21 gain nor S100 gain (Neither), 1q21 gain present but no S100 gain (only 1q21 gain), S100 gain present but no 1q21 gain (only S100 gain), and 1q21 gain and S100 gain present (Both). CNV score > 0.5 indicated a gain event, while <–0.6 is a deletion event. CNV, copy number variation; FIMM, Institute for Molecular Medicine Finland; OS, overall survival; HR, hazard ratio; CI, confidence interval.

Article Snippet: Mononuclear cells were isolated by Ficoll-Paque gradient centrifugation (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom), followed by enrichment of CD138+ plasma cells using the EasySep TM Human CD138 Positive Selection Kit (StemCell Technologies, Vancouver, BC, Canada).

Techniques:

The intestinal microenvironment of Crohn’s disease patients promotes an inflammatory transcriptome in blood monocytes. [A–C] Differentially expressed transcriptomic pathways in blood CD14 + monocytes from healthy donors treated for 5 h with [A] TREM-1 agonist antibody [5 µg/mL], [B] LP-CM from three controls or [C] LP-CM from three Crohn’s disease patients. Quantification of gene expression was done with the NanoString nCounter Human Myeloid Innate Immunity V2 Panel. Pathway signature scores condense each sample’s gene expression profile into a small set of pathway scores. An experiment can then be explored through the lens of pathway signature scores instead of in the much higher-dimension lens of gene expression values. Pathway signature scores are fit using the first principal component of each gene set’s data. They are orientated such that an increasing score corresponds to mostly increasing expression [specifically, each pathway score has positive weights for at least half its genes]. Covariates plots compare pathway signature scores to covariates. Red triangles and green triangles help to show the relative increase and decrease in pathways, respectively, compared to the control condition. [D] The 38 molecules that increased by a minimum two-fold in LP-CM from the three Crohn’s disease patients compared to LP-CM from the three controls. The fold change is based on the mean of the three values per group. [E] LP-CM inflammation score for each sample. This score is the mean of the linear NPX values [see Section 2.6] of the 38 proteins shown in D as a way to get a relative quantification of the inflammation status of the individuals analysed. [F] Correlations between the LP-CM inflammation scores and the top ten increased genes in human blood CD14 + monocytes treated with the Crohn’s disease LP-CM compared to cells treated with the control LP-CM [see ]. [G] Correlations between the LP-CM inflammation scores and the frequency of cells in the same individual determined by flow cytometry [gated as in ]. [F, G] Correlations were assessed by Spearman’s test. Abbreviations: Ctr, controls; LP-CM, lamina propria conditioned media; Mfs, macrophages.

Journal: Journal of Crohn's & Colitis

Article Title: TREM-1 + Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn’s Disease Patients

doi: 10.1093/ecco-jcc/jjab022

Figure Lengend Snippet: The intestinal microenvironment of Crohn’s disease patients promotes an inflammatory transcriptome in blood monocytes. [A–C] Differentially expressed transcriptomic pathways in blood CD14 + monocytes from healthy donors treated for 5 h with [A] TREM-1 agonist antibody [5 µg/mL], [B] LP-CM from three controls or [C] LP-CM from three Crohn’s disease patients. Quantification of gene expression was done with the NanoString nCounter Human Myeloid Innate Immunity V2 Panel. Pathway signature scores condense each sample’s gene expression profile into a small set of pathway scores. An experiment can then be explored through the lens of pathway signature scores instead of in the much higher-dimension lens of gene expression values. Pathway signature scores are fit using the first principal component of each gene set’s data. They are orientated such that an increasing score corresponds to mostly increasing expression [specifically, each pathway score has positive weights for at least half its genes]. Covariates plots compare pathway signature scores to covariates. Red triangles and green triangles help to show the relative increase and decrease in pathways, respectively, compared to the control condition. [D] The 38 molecules that increased by a minimum two-fold in LP-CM from the three Crohn’s disease patients compared to LP-CM from the three controls. The fold change is based on the mean of the three values per group. [E] LP-CM inflammation score for each sample. This score is the mean of the linear NPX values [see Section 2.6] of the 38 proteins shown in D as a way to get a relative quantification of the inflammation status of the individuals analysed. [F] Correlations between the LP-CM inflammation scores and the top ten increased genes in human blood CD14 + monocytes treated with the Crohn’s disease LP-CM compared to cells treated with the control LP-CM [see ]. [G] Correlations between the LP-CM inflammation scores and the frequency of cells in the same individual determined by flow cytometry [gated as in ]. [F, G] Correlations were assessed by Spearman’s test. Abbreviations: Ctr, controls; LP-CM, lamina propria conditioned media; Mfs, macrophages.

Article Snippet: After washing in PBS and removal of erythrocytes as described above, CD14 + monocytes were isolated using CD14 + magnetic beads (EasySep Human CD14 Positive Selection Kit II [Stemcell Technologies, Canada]).

Techniques: Gene Expression, Expressing, Control, Quantitative Proteomics, Flow Cytometry

The intestinal microenvironment of Crohn’s disease patients promotes an inflammatory transcriptome in blood monocytes, which is partly reduced by TREM-1 blockade.

Journal: Journal of Crohn's & Colitis

Article Title: TREM-1 + Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn’s Disease Patients

doi: 10.1093/ecco-jcc/jjab022

Figure Lengend Snippet: The intestinal microenvironment of Crohn’s disease patients promotes an inflammatory transcriptome in blood monocytes, which is partly reduced by TREM-1 blockade.

Article Snippet: After washing in PBS and removal of erythrocytes as described above, CD14 + monocytes were isolated using CD14 + magnetic beads (EasySep Human CD14 Positive Selection Kit II [Stemcell Technologies, Canada]).

Techniques:

IL-6 induced in blood monocytes by Crohn’s disease LP-CM is partially reduced by TREM-1/TNF double blockade. Differentially expressed [A] transcriptomic pathways or [B] CCL3 , CCL4 and IL-6 expression in blood CD14 + monocytes from a healthy donor treated for 5 h with LP-CM from three Crohn’s disease patients plus TREM-1 antagonist antibody [1 µg/mL]. Quantification of gene expression was done with the NanoString nCounter Human Myeloid Innate Immunity V2 Panel. Explanation of pathway signature scores is described in the legend to . [C–E] CCL3 , CCL4 and IL-6 expression, determined by RT-PCR, in human blood CD14 + monocytes treated for 5 h with LP-CM from six additional Crohn’s disease patients plus TREM-1 antagonist antibody alone [1 µg/mL], TNF adalimumab antibody alone [1 µg/mL], or both antibodies together. These blocking experiments were done with the appropriate isotype controls, IgG1 and IgG4, as described in sheet 1. [B–E] Each colour indicates a different individual. [B–E] Data are shown as median values. The difference between paired samples was assessed by a Wilcoxon test; * p vs adalimumab alone. Abbreviations: LP-CM, lamina propria conditioned media.

Journal: Journal of Crohn's & Colitis

Article Title: TREM-1 + Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn’s Disease Patients

doi: 10.1093/ecco-jcc/jjab022

Figure Lengend Snippet: IL-6 induced in blood monocytes by Crohn’s disease LP-CM is partially reduced by TREM-1/TNF double blockade. Differentially expressed [A] transcriptomic pathways or [B] CCL3 , CCL4 and IL-6 expression in blood CD14 + monocytes from a healthy donor treated for 5 h with LP-CM from three Crohn’s disease patients plus TREM-1 antagonist antibody [1 µg/mL]. Quantification of gene expression was done with the NanoString nCounter Human Myeloid Innate Immunity V2 Panel. Explanation of pathway signature scores is described in the legend to . [C–E] CCL3 , CCL4 and IL-6 expression, determined by RT-PCR, in human blood CD14 + monocytes treated for 5 h with LP-CM from six additional Crohn’s disease patients plus TREM-1 antagonist antibody alone [1 µg/mL], TNF adalimumab antibody alone [1 µg/mL], or both antibodies together. These blocking experiments were done with the appropriate isotype controls, IgG1 and IgG4, as described in sheet 1. [B–E] Each colour indicates a different individual. [B–E] Data are shown as median values. The difference between paired samples was assessed by a Wilcoxon test; * p vs adalimumab alone. Abbreviations: LP-CM, lamina propria conditioned media.

Article Snippet: After washing in PBS and removal of erythrocytes as described above, CD14 + monocytes were isolated using CD14 + magnetic beads (EasySep Human CD14 Positive Selection Kit II [Stemcell Technologies, Canada]).

Techniques: Expressing, Gene Expression, Reverse Transcription Polymerase Chain Reaction, Blocking Assay